aminocaproic acid has been researched along with Anemia, Hemolytic in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HASEGAWA, Y | 1 |
TSUKADA, R | 1 |
Ortel, TL | 1 |
Onorato, JJ | 1 |
Bedrosian, CL | 1 |
Kaufman, RE | 1 |
2 other studies available for aminocaproic acid and Anemia, Hemolytic
Article | Year |
---|---|
[RECENT INFORMATION ON THE THERAPY OF BLOOD DISEASES].
Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Aminocaproates; Aminocaproic Acid; Anabolic Age | 1964 |
Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome.
Topics: Adult; Aminocaproic Acid; Anemia, Hemolytic; Antifibrinolytic Agents; Arm; Blood Cell Count; Blood T | 1988 |